antibody#brand name#approval date#type#target
alemtuzumab#campath#2001#humanized#cd52
bevacizumab#avastin#2004#humanized#vascular endothelial growth factor
brentuximab vedotin#adcetris#2011#chimeric#cd30
cetuximab#erbitux#2004#chimeric#epidermal growth factor receptor
gemtuzumab ozogamicin#mylotarg#2000#humanized#cd33
ibritumomab tiuxetan#zevalin#2002#murine#cd20
panitumumab#vectibix#2006#human#epidermal growth factor receptor
rituximab#rituxan , mabthera#1997#chimeric#cd20
trastuzumab#herceptin#1998#humanized#erbb2
